The Paradoxical Effects of AMPK on Insulin Gene Expression and Glucose-Induced Insulin Secretion

Ji-Won Kim1, Young-Hye You1, Dong-Sik Ham1

  • 1Department of Endocrinology & Metabolism, The Catholic University of Korea, Seoul, 137-040, Korea.

Insights

AMP-activated protein kinase (AMPK) activation protects against glucolipotoxicity-induced pancreatic beta-cell dysfunction. This study shows that AMPK activation preserves insulin gene expression and glucose-stimulated insulin secretion (GSIS) under harmful conditions.

Area of Science:

  • Metabolic regulation
  • Cellular dysfunction
  • Diabetes research

Background:

  • AMP-activated protein kinase (AMPK) activation is known to inhibit insulin gene expression and glucose-stimulated insulin secretion (GSIS).
  • Mechanisms underlying AMPK's effects on beta-cell function and its role in glucolipotoxicity remain unclear.
  • Glucolipotoxicity contributes to beta-cell dysfunction, a hallmark of type 2 diabetes mellitus.

Purpose of the Study:

  • To investigate the impact of 5-amino-4-imidazolecarboxamide ribonucleotide (AICAR), an AMPK activator, and peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1α) on beta-cell-specific genes under glucolipotoxic conditions.
  • To evaluate the protective effects of AICAR against glucolipotoxicity-induced beta-cell dysfunction in vitro and in vivo.
  • To explore the role of PGC-1α in mediating these effects.

Main Methods:

  • Real-time PCR was used to measure mRNA expression of insulin and NEUROD1 in isolated rat and human islets.
  • Insulin secretion was assessed in response to glucose stimulation.
  • AICAR was administered to hyperglycemic mice with 90% pancreatectomy to assess in vivo effects on glucose tolerance and insulin secretion.

Main Results:

  • Glucolipotoxicity and PGC-1α overexpression suppressed insulin and NEUROD1 mRNA expression in isolated islets.
  • AICAR treatment and PGC-1α inhibition preserved insulin and NEUROD1 mRNA expression under glucolipotoxic conditions.
  • AICAR treatment and PGC-1α inhibition maintained GSIS in islets exposed to glucolipotoxicity.
  • In vivo, AICAR administration improved glucose tolerance and insulin secretion in hyperglycemic mice.

Conclusions:

  • AMPK activation, via AICAR treatment, protects pancreatic beta-cells against glucolipotoxicity-induced dysfunction.
  • AMPK activation preserves key beta-cell genes and insulin secretion under detrimental metabolic conditions.
  • Targeting AMPK and PGC-1α may offer novel therapeutic strategies for type 2 diabetes by mitigating glucolipotoxicity.

Related Concept Videos

cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
9.3K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
6.2K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
17.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.4K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
8.7K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
3.2K